VNS Therapy Aspire HC Generator and VNS 의 리콜

U.S. Food and Drug Administration에 따르면, 해당 리콜 는 United States 에서 Cyberonics, Inc 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    59818
  • 사례 위험등급
    Class 2
  • 사례 연번
    Z-0210-2012
  • 사례 시작날짜
    2011-08-12
  • 사례 출판 날짜
    2011-11-18
  • 사례 상황
    Terminated
  • 사례 국가
  • 사례 종료 날짜
    2012-08-20
  • 사례 출처
    USFDA
  • 사례 출처 URL
  • 비고 / 경고
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • 데이터 추가 비고
    Stimulator, autonomous nerve, implanted for epilepsy - Product Code LYJ
  • 원인
    The devices are being recalled because the output current delivered to the vagus nerve is less than the design intent and there is a potential charge imbalance at the lead cathode and generator-can during stimulation.
  • 조치
    Cyberonics sent a Field Safety Alert on August 15, 2011, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. The firm decided to recall and initiated contact with implanting facilities in the United States on 08/15/2011. A Field Safety Alert was delivered on 09/19/2011 to implanting facilities. Customers were instructed not to prescribe AspireHC pulse generators for implant until Cyberonics resumes shipment of AspireHC pulse generators that have the issue remedied. Cyberonics recommends that physicians continue their current practice of titrating programming parameters for patients implanted with an AspireHC pulse generator to achieve appropriate clinical outcomes, paying particular attention to report of: Lack or loss of efficacy Pain, inflammation, swelling/edema in the neck area; and/or Patient perception of stimulation or muscle twitching in the area surrounding the implant. Cyberonics recommended routine systems diagnostic testing to aid in device and patient monitoring. Physicians may contact Clinical Technical Support at 866-882-8804 or via email at clinicaltechnicalservices@cyberonics.com. For questions regarding this recall call 281-228-7323.

Device

  • 모델명 / 제조번호(시리얼번호)
    Model 105, VNS Therapy AspireHC Generator
  • 의료기기 분류등급
  • 의료기기 등급
    3
  • 이식된 장치?
    Yes
  • 유통
    Worldwide Distribution - USA including TN, TX, IL, OH, FL, CA, CO, OR, AZ, NY, PA, MO, NJ, WI, OK, MI, ID, KY, IA, MA, NE, GA, LA, NY, and Norway.
  • 제품 설명
    VNS Therapy Aspire HC Generator and VNS, Model 105 || Cyberonics, Inc. 100 Cyberonics Blvd., Houston, TX 77058 || For implantation in humans to treat Epilepsy and Depression.
  • Manufacturer

Manufacturer

  • 제조사 주소
    Cyberonics, Inc, 100 Cyberonics Blvd, Houston TX 77058-2069
  • 제조사 모회사 (2017)
  • Source
    USFDA